Mannkind (MNKD) EBIT Margin (2010 - 2026)

Mannkind's (MNKD) quarterly EBIT Margin came in at 1.85% in Q1 2026, down 3030.0% year-on-year from 0.06% in Q1 2025, and up 73.08% on a QoQ basis from 6.87% in Q4 2025.

Mannkind (MNKD) EBIT Margin (2010 - 2026) Analysis & Trends

Mannkind (MNKD) has 14 years of EBIT Margin data on file, last reported at 1.85% in Q1 2026.

  • On a quarterly basis, EBIT Margin fell 3030.0% year-over-year to 1.85% in Q1 2026; TTM through Mar 2026 was 4.11%, a 2215.0% decrease from a year earlier, with the FY2025 full-year figure at 11.12%, down 1431.0% from the prior year.
  • EBIT Margin for Q1 2026 stood at 1.85%, up from 6.87% in the prior quarter.
  • Over the last five years, EBIT Margin for MNKD reached as high as 34.51% in Q4 2024 and fell as low as 177.25% in Q1 2022.
  • Historically, EBIT Margin has averaged 11.03% across 5 years, with a median of 6.92% in 2025.
  • Across the five-year window, EBIT Margin sank 14174 bps in 2022 and surged 16249 bps in 2023, its largest moves.
  • Year by year, EBIT Margin stood at 35.47% in 2022, then surged by 138 bps to 13.44% in 2023, then jumped by 157 bps to 34.51% in 2024, then plunged by 120 bps to 6.87% in 2025, then soared by 73 bps to 1.85% in 2026.
  • Per Business Quant data, the three most recent EBIT Margin figures were 1.85% in Q1 2026, 6.87% in Q4 2025, and 23.01% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 16.51%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 38.10%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 17.83%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 31.68%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Mannkind 1.20 Bn 1.07 Bn 82.66 Mn -1.85%

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.85%
Dec 31, 2025 -6.87%
Sep 30, 2025 23.01%
Jun 30, 2025 6.92%
Mar 31, 2025 28.45%
Dec 31, 2024 34.51%
Sep 30, 2024 18.21%
Jun 30, 2024 22.95%
Mar 31, 2024 25.24%
Dec 31, 2023 13.44%
Sep 30, 2023 9.94%
Jun 30, 2023 3.54%
Mar 31, 2023 -14.76%
Dec 31, 2022 -35.47%
Sep 30, 2022 -29.28%
Jun 30, 2022 -108.26%
Mar 31, 2022 -177.25%
Dec 31, 2021 -191.51%
Sep 30, 2021 -29.67%
Jun 30, 2021 -44.13%